Preview Mode Links will not work in preview mode
Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape.  Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes  Value-based healthcare  Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials  Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.

Apr 15, 2020

Dr. Gregory Frost, Chairman and CEO, EXUMA Biotech, shares his insights into the tremendous progress made in developing autologous CAR-T therapies, as well as the challenges that remain for cell therapies surrounding safety and accessibility.  EXUMA's rapid point of care platform has the potential to dramatically reduce the cost of CAR-T production for both liquid and solid tumors.  Greg also describes their logic-gated CAR-T technology which may help avoid potential on-target, off-tumor toxicity in solid tumor malignancies such as gastric, breast and ovarian cancers.

@EXUMABiotech

#EXUMABiotech #CART #CellTherapy #immunotherapy

EXUMABio.com

Download the transcript here

 

EXUMA